Cmax (mg/ l) – 0, 39 (31%), Tmax (h) – ge
20 Mean (CV%) steady state pharmacokinetic parameters estimates of fondaparinux in patients undergoing hip replacement surgery receiving fondaparinux 2.5 mg once daily are: